Kimberly Ha

Background

About Kimberly Ha

I advise life sciences companies and VC funds through their most critical, high-stakes moments, from company launches and financings to IPOs, M&A, licensing deals, regulatory milestones, and crises, as Founder and CEO of KKH Advisors, a strategic communications firm. Founded in 2018, KKH has helped launch 100+ biotech startups and venture funds and is trusted behind the scenes of some of the industry’s most defining transactions. We advise both private and public companies. With 20+ years spanning media, capital markets, and biotech, I bring a rare blend of financial communications expertise and journalistic insight. Previously, I was Senior Director on the Life Sciences Capital Markets team at FTI Consulting (NYSE: FCN) and Global Editor of BioPharm Insight (Financial Times Group), covering market-moving biotech news, M&A, and regulatory news. An award-winning journalist and National Press Foundation Fellow, I frequently speak at biotech conferences, universities, and accelerators. I am also a Limited Partner at Array Ventures, a deeptech fund.